Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay

Clinical trial NCT06112301 · COMPLETED

Trial details

NCT number: NCT06112301
Sponsor: Invivoscribe, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

B-Cell Lymphoproliferative Disorder

Start date: 2024-01-02
Primary completion: 2024-11-06
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.